Metacognitive Therapy Compared to Cognitive-behavioral Therapy
Recruiting · NCT07382323 · Interventional (participants receive a specific treatment) · Lead sponsor: Karolinska Institutet
View the official record on ClinicalTrials.gov →Interventions studied
Disorder-specific cognitive-behavioral therapyTransdiagnostic metacognitive therapy
What this trial is about
This is a qualitative study of participants who have taken part in a randomized controlled trial comparing transdiagnostic metacognitive therapy and disorder-specific cognitive-behavioral therapy for anxiety disorders. The purpose of the study is to explore participant perceptions of the respective treatment models to facilitate implementation and dissemination of the treatments.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age 18 years or older,
- A principal diagnosis of generalized anxiety disorder, social anxiety disorder, or posttraumatic stress disorder,
- No change in dose during the last six weeks if on pharmacological treatment, and
- Ability to read and speak Swedish.
Exclusion criteria
- A current diagnosis of psychotic disorder, bipolar disorder, neurocognitive disorder, or moderate to severe substance use disorder,
- Acute suicide risk, or
- Concurrent psychological treatment.
Where it is running
1 location listed.
- Northern Stockholm Psychiatry Clinic - Stockholm, Sweden